Regulatory Challenges at the Intersection of Cellular and Medical Device Therapies in Europe: The Case of the Bioartificial Pancreas
Regenerative medicine solutions for type 1 diabetes are a rapidly developing field of medical technology. So far, these solutions have been principally cell-based treatments and, at present, in Europe, are regulated under the European Union regulations for Advanced Therapy Medicinal Products (ATMPs)...
Na minha lista:
| Principais autores: | , , |
|---|---|
| Format: | Artigo |
| Sprog: | Inglês |
| Udgivet: |
Queensland University of Technology
2023-11-01
|
| Serier: | Law, Technology and Humans |
| Fag: | |
| Online adgang: | https://lthj.qut.edu.au/article/view/3118 |
| Tags: |
Ingen Tags, Vær først til at tagge denne postø!
|